I'm struggling to understand what is going on with Nymagee. My understanding (solely from ASX releases) is that Nymagee was deferred in 2019 after PFS investigations found:
met issues (presence of talc and pyrrhotite) would lead to lower than expected recoveries and
harder than expected rock would increase costs beyond expectations.
The company obviously believes it can overcome these issues and improve project viability somehow (higher grades would do it). Some more information would be nice.
AMI Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)